Compumedics (ASX:CMP) Cash Flow from Operations: A$4.37 Mil (TTM As of Dec. 2025)


ASX:CMP Compumedics Ltd ASX:CMP
62 GF Score
Price A$0.27
GF Value A$0.32
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Compumedics Cash Flow from Operations?

Compumedics ASX:CMP +12.50% 62 Cash Flow from Operations is A$4.37 Mil as of Dec. 2025. GuruFocus rates ASX:CMP with a GF Score™ of 62/100 and a GF Value™ of A$0.32 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Cash flow from operations refers to the cash brought in through a company's normal business operations. It is the cash flow before any investment or financing activities. It is the cash version of net income.

For the six months ended in Dec. 2025, Compumedics's Cash Receipts from Operating Activities was A$32.47 Mil. Its Cash Payments was A$-29.94 Mil. Its Dividends Paid was A$0.00 Mil. Its Dividends Received was A$0.00 Mil. Its Interest Paid was A$-0.74 Mil. Its Interest Received was A$0.00 Mil. Its Taxes Refund Paid was A$0.00 Mil. And its Cash Flow from Others was A$0.00 Mil. In all, Compumedics's Cash Flow from Operations for the six months ended in Dec. 2025 was A$1.80 Mil.


Compumedics  (ASX:CMP) Cash Flow from Operations Explanation

For non-financial companies reported in direct method, cash flow from operations contains eight items:

1. Cash Receipts from Operating Activities:
Cash Receipts from Operating Activities represents cash received from operating activitiies in direct method.

Compumedics's cash receipts from operating activities for the six months ended in Dec. 2025 was A$32.47 Mil.

2. Cash Payments:
It represents cash flow paid from operating activities in the direct cash flow method.

Compumedics's cash payments for the six months ended in Dec. 2025 was A$-29.94 Mil.

3. Dividends Paid:
It represents dividend paid to the investors in the direct cash flow method.

Compumedics's cash payments for the six months ended in Dec. 2025 was A$0.00 Mil.

4. Dividends Received:
It represents dividend received on the investment in the direct cash flow method.

Compumedics's cash payments for the six months ended in Dec. 2025 was A$0.00 Mil.

5. Interest Paid:
It represents interest paid on loans, debt or borrowings, in the direct cash flow method.

Compumedics's cash payments for the six months ended in Dec. 2025 was A$-0.74 Mil.

6. Interest Received:
It represents interest received by the company in the direct cash flow method.

Compumedics's cash payments for the six months ended in Dec. 2025 was A$0.00 Mil.

7. Taxes Refund Paid:
It represents tax paid or refund related to operating activities in the direct cash flow method.

Compumedics's cash payments for the six months ended in Dec. 2025 was A$0.00 Mil.

8. Cash Flow from Others:
These are cash differences caused by the change of cash receipts and cash payments. For instance, if a company pays its suppliers slower, its cash position will build up faster. If a company receives payments from its customers slower, its cash position will grow more slowly (or even shrink).

Compumedics's cash flow from others for the six months ended in Dec. 2025 was A$0.00 Mil.


Compumedics Cash Flow from Operations Related Terms


Compumedics Cash Flow from Operations Historical Data

* Premium members only.

The historical data trend for Compumedics's Cash Flow from Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Compumedics Cash Flow from Operations Chart

Compumedics Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Cash Flow from Operations
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.61 3.38 0.05 3.37 0.45

Compumedics Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Cash Flow from Operations Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.17 2.20 -2.12 2.57 1.80
ASX:CMP
62GF Score
Compumedics Ltd ASX:CMP
Cash Flow from Operations is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Compumedics Cash Flow from Operations Calculation

Cash flow from operations refers to the cash brought in through a company's normal business operations. It is the cash flow before any investment or financing activities. It is the cash version of net income.

Compumedics's Cash Flow from Operations for the fiscal year that ended in Jun. 2025 is calculated as:

Compumedics's Cash Flow from Operations for the quarter that ended in Dec. 2025 is:


Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$4.37 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow from Operations of A$4.37 Mil mean?
Compumedics (ASX:CMP) has a Cash Flow from Operations of A$4.37 Mil as of Dec. 2025. Cash Flow from Operations is the amount of cash earned or paid from standard business operations. View historical data for Compumedics and its competitors.
Is Compumedics' Cash Flow from Operations too high?
Compumedics' current Cash Flow from Operations is A$4.37 Mil. Overall, Compumedics has a GF Score™ of 62/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Compumedics' Cash Flow from Operations compare to ABT and SYK?
Compumedics' Cash Flow from Operations of A$4.37 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow from Operations for a Medical Devices & Instruments company?
A good Cash Flow from Operations depends on the Medical Devices & Instruments industry context. However, Cash Flow from Operations should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow from Operations mean?
A high Cash Flow from Operations can signal that a stock is expensive relative to its fundamentals. Cash Flow from Operations is the amount of cash earned or paid from standard business operations. View historical data for Compumedics and its competitors. Compumedics's current Cash Flow from Operations is A$4.37 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Compumedics stock overvalued right now?
Based on GuruFocus' analysis, Compumedics (ASX:CMP) is currently considered Modestly Undervalued. The stock's GF Value™ is A$0.32, compared to a current price of A$0.27 — trading 15.6% below its estimated fair value. The current Cash Flow from Operations is A$4.37 Mil. Compumedics' overall GF Score™ is 62/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow from Operations calculated?
Cash Flow from Operations is calculated from a company's financial statements. For Compumedics (ASX:CMP), the current Cash Flow from Operations is A$4.37 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Compumedics (ASX:CMP) Overvalued in 2026?

Based on GuruFocus' analysis, Compumedics stock appears to be undervalued. The current stock price of A$0.27 is trading 15.6% below its estimated GF Value™ of A$0.32. GuruFocus considers Compumedics to be Modestly Undervalued.

Key valuation signals for ASX:CMP:

  • Cash Flow from Operations: A$4.37 Mil
  • GF Value™: A$0.32 vs. price of A$0.27 (15.6% below fair value)
  • GF Score™: 62/100 with 4 warning signs

No single metric tells the full story. See the ASX:CMP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Compumedics Business Description

Address 30-40 Flockhart Street, Abbotsford, Melbourne, VIC, AUS, 3067
Compumedics Ltd is a medical device company. It is engaged in the development, manufacturing, and commercialization of diagnostic technologies for sleep, brain, and ultrasonic blood-flow monitoring applications. The company is organized into geographical operating segments, being the United States of America, Australia and Asia Pacific, and Europe and the Middle East. It derives a majority of its revenue from Australia and the Asia Pacific region.
62GF Score

Get the complete analysis for ASX:CMP

Cash Flow from Operations is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.27
Price
A$0.32
GF Value